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Ubiquitylation is an essential posttranslational protein modiﬁcation that is implicated in a diverse array
of cellular functions. Although cells contain eight structurally distinct types of polyubiquitin chains,
detailed function of several chain types including K29-linked chains has remained largely unclear. Cur-
rent mass spectrometry (MS)-based quantiﬁcation methods are highly inefﬁcient for low abundant atyp-
ical chains, such as K29- and M1-linked chains, in complex mixtures that typically contain highly
abundant proteins. In this study, we applied parallel reaction monitoring (PRM), a quantitative, high-res-
olution MS method, to quantify ubiquitin chains. The ubiquitin PRM method allows us to quantify
100 attomole amounts of all possible ubiquitin chains in cell extracts. Furthermore, we quantiﬁed ubiq-
uitylation levels of ubiquitin-proline-b-galactosidase (Ub-P-bgal), a historically known model substrate
of the ubiquitin fusion degradation (UFD) pathway. In wild-type cells, Ub-P-bgal is modiﬁed with ubiq-
uitin chains consisting of 21% K29- and 78% K48-linked chains. In contrast, K29-linked chains are not
detected in UFD4 knockout cells, suggesting that Ufd4 assembles the K29-linked ubiquitin chain(s) on
Ub-P-bgal in vivo. Thus, the ubiquitin PRM is a novel, useful, quantitative method for analyzing the highly
complicated ubiquitin system.
 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
Protein ubiquitylation is an essential post-translational modiﬁ-
cation responsible for targeted protein degradation, cellular signal-
ing activation, DNA damage response, and intracellular protein
trafﬁcking, and protein quality control [1–3]. Ubiquitylation is
achieved by the concerted action of activating (E1), conjugating
(E2) and ligating (E3) enzymes, some of which possess elongating
activities that support the generation of polyubiquitin chains. Pro-
teins can be modiﬁed through the conjugation of monoubiquitin or
polyubiquitin chains of variable lengths on any of the seven Lys (K)
residues (K6, K11, K27, K29, K33, K48 or K63) or the amino-termi-
nal Met (M1) of the ubiquitin monomer. Ubiquitin chains can thus
be connected by at least eight different homotypic linkages, as well
as by a range of heterogeneous chains (forked or mixed) [3]. Occa-
sionally, efﬁcient protein polyubiquitylation requires additionalconjugation factor, so-called E4 enzyme, that supports the elonga-
tion of ubiquitin chains [4,5]. The topologically distinct polyubiqu-
itin chains result in the different biological consequences. For
example, K48-linked chains function as a targeting signal for pro-
teasomal destruction, whereas K63-linked chains are used in
DNA repair and the trafﬁcking of membrane proteins. However,
the functions of atypical chains linked through M1, K6, K11, K27,
K29, or K33 are only beginning to emerge, and the roles of mixed
or branched chains are unknown [6]. Ubiquitin receptors, many
of which display speciﬁcity or preference for ubiquitin chain types
or length, play a key role in decoding the signals embedded in the
structure of ubiquitin chains [7].
To understand the biological signiﬁcance of different ubiquitin
chain topologies, it is essential to study the dynamics of protein
ubiquitylation in endogenous settings [8]. Currently, a MS-based
strategy is a most powerful and sensitive method to analyze
endogenous ubiquitylation events in cells [6]. The ubiquitin-abso-
lute quantiﬁcation (AQUA) method was established to quantify
individual ubiquitylated protein substrates [9] or afﬁnity-captured
ubiquitin chain mixtures from cells [10]. The method involves
using isotopically labeled internal standard ubiquitin peptides.
Peptides in the sample are generated by digestion of polyubiquitin
chains with trypsin. Both unlabeled sample peptides and isotopi-
cally labeled internal standards can be analyzed by selected reac-
tion monitoring (SRM) on a triple quadrupole (QQQ) MS or by
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Orbitrap MS [9,11,12]. Nevertheless, in the complex mixtures that
typically contain highly abundant species of ubiquitin chains (e.g.,
K48 chain), MS-based quantiﬁcation of the low abundant atypical
chains, such as K29-linked and M1-linked chains, is still limited
[12].
Recently, a new targeted proteomics method using a next gen-
eration, quadrupole-equipped Orbitrap instrument (Q Exactve),
called parallel reaction monitoring (PRM), has been proposed
[13,14]. The Q Exactive is like a QQQ except that the third quadru-
pole is replaced with a high-resolution, high-mass accuracy Orbi-
trap mass analyzer [13]. Whereas in SRM, all transitions are
monitored one at a time, PRM allows parallel detection of all tran-
sitions in a single analysis. PRM yielded quantitative data over a
wider dynamic range than SRM in the complex biological matrix
due to PRM’s high selectivity in the mass-to-charge domain
[14,15].
In this study, we applied the PRM method to quantify poly-
ubiquitin chains in biological matrices and succeeded in the quan-
tiﬁcation of all the linkages from 50 amol to 100 fmol. Using the
ubiquitin PRM, we dissected the ubiquitylation of ubiquitin-pro-
line-b-galactosidase (Ub-P-bgal), a substrate of the ubiquitin fusion
degradation (UFD) pathway [16], and unambiguously identiﬁed
that K29-linked ubiquitin chains are attached to Ub-P-bgal
in vivo. Thus, the ubiquitin PRM is a highly sensitive and reliable
method to analyze the complicated ubiquitin system.2. Materials and methods
2.1. Yeast strains
Saccharomyces cerevisiae strains used are listed in Supplemen-
tary Table 1.2.2. Immunoprecipitation and Western blotting
Yeast cultures were grown in SC medium (0.67% yeast nitrogen
base without amino acids, 0.5% casamino acid, 2% glucose, and
20 mg/l uracil) to an OD600 of 0.8 at 28 C. Cells (200 OD600) were
harvested and lysed using glass beads in 400 ll of lysis buffer
(50 mM Tris–HCl, pH 7.5, 100 mM NaCl, 10% glycerol, 10 lMTable 1
List of the ubiquitin peptides used in PRM analysis.
Abbreviation Peptide sequence Precurso
TITLE TITLEVESSDTIDNVLK 882.449
TITLEVESSDTIDNV[HeavyV]K 885.456
EST ESTLHLVLR 534.314
ESTLHLVL[HeavyL]R 537.823
K6 (ox) M[Oxid]QIFVK[di-GlyGly]TLTGK 465.927
M[Oxid]QIFVK[di-GlyGly]TL[HeavyL]TGK 468.266
K11 TLTGK[di-GlyGly]TITLEVESSDTIDNVK 793.415
TLTGK[di-GlyGly]TITLEVESSDTIDNV[HeavyV]K 795.419
K27 TITLEVESSDTIDNVK[di-GlyGly]SK 698.358
TITLEVESSDTIDNV[HeavyV]K[di-GlyGly]SK 700.363
K29 SK[di-GlyGly]IQDK 416.730
SK[di-GlyGly]I[HeavyI]QDK 420.238
K33 IQDK[di-GlyGly]EGIPPDQQR 546.613
IQDK[di-GlyGly]EGIPP[HeavyP]DQQR 548.618
K48 LIFAGK[di-GlyGly]QLEDGR 487.6 (+
LIFAGK[di-GlyGly]QL[HeavyL]EDGR 489.939
K63 TLSDYNIQK[di-GlyGly]ESTLHLVLR 561.805
TLSDYNIQK[di-GlyGly]ESTLHLVL[HeavyL]R 563.559
M1 (ox) GGM[Oxid]QIFVK 448.239
GGM[Oxid]QIFV[HeavyV]K 451.246
The oxidation state of Met containing peptides is denoted by (ox) for sulfoxide. In the pep
(di-GlyGly), and the Met oxidation (Oxid) are in the blankets. For each peptide, the optiMG132, 10 mM iodoacetamide, and 1 X complete protease inhibi-
tor cocktail (Roche, EDTA free)). After addition of 600 ll of lysis
buffer containing 0.2% TX-100, the extracts were centrifuged at
20,000 x g for 20 min. The supernatants were recovered and immu-
noprecipitated with 11 lg anti-bgal monoclonal antibody (Prome-
ga) preadsorbed with 1.5 mg of Dynabeads Protein G (Life
Technologies) for 30 min at 4 C. After washing three times with ly-
sis buffer containing 0.2% TX-100, the proteins were eluted with 1
X NuPAGE LDS sample buffer for 10 min at 70 C. The proteins were
separated by SDS–PAGE on 4–12% NuPAGE Bis-Tris gels with MES
buffer (Life Technologies). For mass spectrometric analysis, the gels
were stained with Bio-Safe Coomassie (BioRad).
For Western blotting, the proteins were blotted onto a PVDF
membrane using the NuPAGE immunoblotting system (Life Tech-
nologies). The membranes were probed with anti-bgal or anti-
ubiquitin monoclonal antibody (P4D1, HRP conjugated, Santa
Cruz).
2.3. Preparation of internal AQUA peptides
Synthetic isotopically labeled peptides were purchased from
Sigma (Custom AQUA peptides) or Thermo Fisher Scientiﬁc (AQUA
Ultimate grade) as listed in Table 1. The peptides were dissolved or
diluted in 10% acetonitrile (ACN)/0.1% formic acid (FA) and mixed
at a ﬁnal concentration of 200 fmol/ll. The peptide mixtures were
divided to small aliquots and stocked at 80 C. We noted that the
use of Protein Lobind tube (Eppendorf) signiﬁcantly improved the
stabilities of the ubiquitin peptides.
2.4. Trypsin digestion and sample preparations
In-gel trypsin digestion was carried out as described in a proto-
col by Phu et al. [12] with modiﬁcations. After the gels were exten-
sively washed with Milli-Q water (Millipore), gels were excised,
diced into 1 mm3 pieces, and destained by 1 ml of 50 mM ammo-
nium bicarbonate (AMBC)/30% ACN with agitation for 1 h, then the
gels were further washed by 1 ml of 50 mM AMBC/50% ACN for 1 h.
Finally, 100% ACN wash was performed to ensure complete gel
dehydration. Trypsinization solution (20 ng/ll) was prepared on
ice by dilution of modiﬁed sequencing grade trypsin (Promega)
using pre-chilled 50 mM AMBC/5% ACN pH 8.0. Trypsin solution
was subsequently added to gel pieces at approximately equivalentr m/z (charge state) Product ions for PRM RT min
(+2) y3+, y5+, y6+, y8+, y10+, y11+, y12+, y14+ 53.76
(+2)
(+2) y3+, y4+, y5+, y6+, y7+, y8+ 39.37
(+2)
(+3) y3+, y4+, y5+, y6+, y7+ 38.62
(+3)
(+3) y5+, y7+, y8+, y9+, y10+, y11+, 57.54
(+3)
(+3) y5+, y6+, y7+, y8+, y9+, y10+, y11+ 47.85
(+3)
(+2) y2+, y3+, y4+, y5+ 21.44
(+2)
(+3) y3+, y4+, y5+, y6+ 22.42
(+3)
3) y3+, y5+, y6+, y8+, y9+ 40.52
(+3)
(+4) 748.738 (+3) y5+, y9+, y10+ 57.64
(+4) 751.077 (+3)
(+2) y2+, y3+, y4+, y5+, y6+ 28.53
(+2)
tide sequences, isotopically labeled amino acids (Heavy: 13C15N), ubiquitylation site
mal precursor ion(s), product ions, and retention times are shown.
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trypsin solution was added to gel samples and incubated at 37 C
for overnight. Digests were quenched and extracted by addition
of 50 ll of 50% ACN/0.1% triﬂuoroacetic acid (TFA) for 1 h by shak-
ing. The digested peptides were recovered into fresh Protein Lo-
bind tubes and additional extraction step was performed with
70% ACN/0.1% TFA for 30 min. The extracted peptides were com-
bined and concentrated to 15 ll by a speed-vac. The concentrated
peptides were mixed with 50 fmol of ubiquitin AQUA peptides,
2.5 ll of 1% TFA, and 2.5 ll of 0.05% H2O2 in a total volume of
25 ll and were incubated at 4 C for overnight to oxidize Met
[12]. Note that we used 0.1% TFA instead of FA for sample prepara-
tion to improve the peak shape of K29-linked ubiquitin peptide for
reliable quantiﬁcation.A
B
Fig. 1. Ubiquitin quantiﬁcation by parallel reaction monitoring analysis. (A) Workﬂow f
(PRM). After proteins are separated by SDS–PAGE, the gel regions of interest were excis
were spiked in the extracted peptides and treated with hydrogen peroxide for oxidation o
in targeted MS/MS mode. (i) Total ion chromatogram (TIC) of PRM analysis of wild-type y
peptide (+4, m/z = 561.805). The product ions used in the PRM analysis were indicated b
both peptides. Identical elution times were observed between the light (endogenous) a
established by PRM analysis from the dilution series of ﬁve internal standards (50 amol–
(See Table 1 for their abbreviations), a limit of detection of 50 amol was determined (Su2.5. Liquid chromatography and mass spectrometry
A nanoﬂow UHPLC instrument (Easy nLC 1000, Thermo Fisher
Scientiﬁc) was coupled on-line to a Q Exactive MS (Thermo Fisher
Scientiﬁc) with a nanoelectrospray ion source (Thermo Fisher Sci-
entiﬁc). Because K29-linked ubiquitin peptide is very hydrophilic,
the samples were directly loaded onto a C18 analytical column
(Reprosil-Pur 3 lm, 75 lm id x 12 cm packed tip column, Nikkyo
Technos Co. Ltd.). For ionization, 1.8 kV of liquid junction voltage
and 250 C capillary temperature were used. Reversed phase chro-
matography was performed using the Thermo EASY-nLC 1000 with
a binary buffer system consisting of 0.1% FA (solvent A) and 100%
ACN/0.1% FA (solvent B) with a ﬂow rate of 300 nl/min. For shotgun
analysis, the peptides were separated using a 12 min 2-stepor the absolute quantiﬁcation of ubiquitin peptides by parallel reaction monitoring
ed from the gel and subjected to in-gel trypsin digestion. Ubiquitin AQUA peptides
f Met-containing peptides. The samples were analyzed by a Quadrupole-Orbitrap MS
east lysate with 10 fmol of Ub AQUA peptides. (ii) MS/MS spectra of endogenous K63
y red circles (y5+, y9+, and y10+). (iii) The chromatogram of selected product ions of
nd heavy (internal control) counterparts. (B) Linearity range of the dilution curves
100 fmol) prepared in 500 ng of E. coli digest. For all ubiquitin peptides except TITLE
pplementary Fig. 1).
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Fig. 2. Expression levels of Ub-P-bgal in mutant cells. (A) Steady state levels of Ub-P-bgal in BY4741 (WT: wild-type), E3 knockout (Dufd4), and E4 knockout (Dufd2) cells.
Total cell extracts of the cells stably expressing Ub-P-bgal (WT, YHT20; Dufd4, YHT24; Dufd2, YHT26) were analyzed by Western-blotting with anti-bgal (upper). The cells
were lysed and Ub-P-bgal was puriﬁed on anti-bgal beads and analyzed by Western-blotting with anti-bgal or anti-ubiquitin antibodies (middle and bottom).
Polyubiquitinated (Ubn) species of Ub-P-bgal are indicated by a half square bracket. (B) SDS–PAGE analysis of the puriﬁed Ub-P-bgal. Puriﬁed proteins in (A) were subjected to
SDS–PAGE followed by Coomassie Brilliant Blue-staining. The protein bands corresponding to Ub-P-bgal, the IgG heavy chain (IgH), and the IgG light chain (IgL) are indicated.
Unassigned protein bands (a–c) were analyzed by LC-MS/MS. Identiﬁed proteins with high score are listed in right table and the sequence coverage of the identiﬁed proteins
is indicated in parenthesis. The gel regions analyzed by ubiquitin-PRM in Fig. 3 are indicated by Ubn-Ub-P-bgal.
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The Q Exactive was operated in the data dependent mode, using
Xcalibur software, with survey scans acquired at a resolution of
70,000 at m/z 200. Up to the top 10 most abundant isotope pat-
terns with charge 2  5 from the survey scan were selected with
an isolation window of 1.2 Th and fragmented by HCD with nor-
malized collision energies of 28. The maximum ion injection times
for the survey scan and the MS/MS scans were 60 ms, respectively
and the ion target values were set to 3e6 and 1e6, respectively. Se-
lected sequenced ions were dynamically excluded for 90 sec. For
parallel reaction monitoring (PRM) quantiﬁcation, the peptides
were separated using an 80 min 3-step gradient (0–10% in 5 min,
10–25% in 70 min, and 25–80% in 5 min of solvent B). The Q Exac-
tive was operated in the targeted MS/MS mode, using Xcalibur
software, with time-scheduled acquisition of the 11 pairs of isoto-
pically labeled peptides/endogenous peptides in +/ 6 min reten-
tion time windows (list in Table 1) with 2 Th individual isolation
windows. The target ion values was 1e6, and maximum ion ﬁll
times was 200 ms. Fragmentation was performed with normalized
collision energy of 27 and MS/MS scans were acquired with a at a
resolution of 70,000 at m/z 200. We used a hydrophilic MS vial
(ProteoSave, AMR Inc.) to avoid nonspeciﬁc peptide adsorption.
To characterize the linear range of ubiquitin quantiﬁcation, we di-
luted the ubiquitin AQUA peptide mixtures in 0.1% TFA, 0.05%
H2O2, and 100 ng/ll and Escherichia colimatrix (MassPREP, Waters)
and incubated at 4 C for overnight. Then, 5 ll of samples corre-
sponding to 0.05, 0.1, 1, 10, and 100 fmol of ubiquitin peptides
with 500 ng E. coli matrix were subjected to the PRM analysis.2.6. Protein identiﬁcation and quantiﬁcation from MS data
For protein identiﬁcation, MS spectra were analyzed using Pro-
tein Discoverer software version 1.3 (Thermo Fisher Scientiﬁc). The
fragmentation spectra were searched against UniProt database
with the amino acid sequence information of Ub-P-bgal using the
SEQUEST search engine. The precursor and fragment mass toler-
ances set to 10 ppm and 20 ppm, respectively. Oxidation of Met
and protein N-terminal acetylation were chosen as variable modi-
ﬁcations for database searching. Peptide identiﬁcation was ﬁlteredat 1% false discovery rate. For ubiquitin quantiﬁcation, raw ﬁles
were processed by PinPoint software version 1.3 (Thermo Fisher
Scientiﬁc). Ion chromatograms were extracted with a mass toler-
ance of 5 ppm for PRM data. The area under the curve (AUC) of se-
lected fragment ion (PRM analysis, list of selected transitions in
Table 1) was calculated for each sampling point based on the co-
elution proﬁles of differently labeled peptides. The AUCs of each
individual PRM transition were then summed to obtain AUCs at
the peptide level [15]. The linearity range of measurement of each
peptide was deﬁned as the range of spiked peptide amounts for
which the relative difference between deduced values of peptide
area ratio from regression analysis and experimentally determined
ones was lower than 15%. The composite MS/MS spectrum of each
targeted peptide was reconstructed from the AUCs of the three to
eight transitions selected for the peptide. The identity of targeted
peptides was veriﬁed by the correlation between the composite
MS/MS spectrum and the MS/MS spectral library entry, assessed
by the calculation of a Bonferroni corrected p-value of correlation
[17]. The peptide that gave a p-value less than 0.05 was considered
to be conﬁdently conﬁrmed by the library match.3. Results and discussion
3.1. Ubiquitin quantiﬁcation by Q-Q-Orbitrap mass spectrometry
Based on the previous MS method to use synthetic di-Gly-
tagged peptides as internal standards for quantifying ubiquitin
linkages [9,12], we established a more precise method to measure
ubiquitin chains by using a quadrupole-equipped Orbitrap in tar-
geted MS/MS mode (Fig. 1). Protein samples were subjected to
SDS–PAGE followed by in-gel trypsinization according to the previ-
ous study [12]. To minimalize sample loss and experimental errors,
the extracted peptides were directly subjected to LC-MS/MS anal-
ysis. After spiking with ubiquitin AQUA peptides, the samples were
treated with 0.05% H2O2 in 0.1% TFA at 4 C for 12 h to oxidize the
Met-containing peptides, M1- and K6-linkages, according to a pre-
vious study [12]. Under the condition, we conﬁrmed that >95% of
the Met-peptides were converted to the oxidized form (data not
shown). During instrumental setup, we found that K29-linked
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as a broad peak in the nanoﬂow UHPLC system probably due to the
hydrophilicity. To overcome this problem, we used one-column
setting that peptide samples were directly loaded onto the analyt-
ical column. We also noticed that 0.1% TFA instead of 0.5% FA for
sample preparation dramatically improves the peak shape of
K29-linked ubiquitin peptide (see Supplementary Figs. 1 and 2).
To minimalize nonspeciﬁc adsorption to tubes or vials, especially
occurred in K63-linked peptide, we used a hydrophilic tube and
MS vial throughout the analysis.
We ﬁrst analyzed wild-type yeast lysate by PRM (Fig. 1A and
Table 1). The lysate (10 lg) was separated by SDS–PAGE and the
gel region above 62 kDa was subjected in-gel trypsinization. The
extracted peptides were spiked with 10 fmol of the ubiquitin AQUA
peptides and analyzed by Q Exactive in targeted MS/MS mode. As
expected, total ion chromatogram (TIC) was relatively complex
even in the targeted MS/MS mode. Ion chromatograms wereA
B
Fig. 3. Ufd4 attaches K29-linked ubiquitin chains to Ub-P-bgal in vivo. (A) Summary o
YHT20, YHT24, and YHT26 cells were simply denoted as control, WT,Dufd4,Dufd2, respec
ubiquitin peptides with high abundance (>1 fmol) are indicated in red text. (mean ± s.e.m
A possible model of the UFD pathway. Ufd4 recognizes UFD substrate and attaches K29-liextracted with a mass tolerance of 5 ppm from at least 3 fragment
ions (Fig. 1A, ii for K63-linked peptide). The area under the curve
(AUC) of selected fragment ions was calculated for each sampling
point based on the co-elution proﬁles of differently labeled pep-
tides (Fig. 1A, ii for K63-linked peptide). We optimized PRM tran-
sition, the charge state of precursor ions and well resolved
fragment ions, by manually or using PinPoint software [15]. The
AUCs of each individual PRM transition were then summed to ob-
tain AUCs at peptide level. Using the ubiquitin PRM, all the ubiqui-
tin peptides except M1- and K27-linkages were unambiguously
detected from yeast extract (data not shown).
To establish standard curves of ubiquitin peptides in biological
samples, the ubiquitin AQUA peptide mixtures were serially di-
luted in E. coli matrix and subjected to the PRM analysis (Fig. 1
B). Because two peptides, TITLE and EST (see Table 1), detected eas-
ily even in complex samples, total ubiquitin levels were assessed
by these ubiquitin peptides (data not shown). We could detectC
f ubiquitylation levels on Ub-P-bgal by ubiquitin-PRM. The samples from BY4741,
tively. Total ubiquitin were quantiﬁed by two ubiquitin peptides, TITLE and EST. The
.; n = 3 biological replicates). (B) Pie chart of the abundance of ubiquitin linkages. (C)
nked chain. Subsequently, Ufd2 elongates the ubiquitin chains via K48-lined chains.
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100 amol in the presence of biological matrices. Standard curves
were obtained with R2 > 0.999 (Fig. 1B and Supplementary Fig. 1).
By the ubiquitin PRM, quantitation can be performed across at
least 3 orders of magnitude with all the ubiquitin peptides being
quantiﬁable from 0.1 fmol to >100 fmol. From our knowledge,
the ubiquitin PRM method is highest sensitive method to quantify
ubiquitins to date.
3.2. Quantiﬁcation of the ubiquitylation levels of a ubiquitin fusion
degradation substrate
The UFD pathway is responsible for ubiquitylation of the fusion
proteins that bear a ‘‘non-removable’’ N-terminal Ub moiety,
which serves as a degron [16]. The UFD pathway is conserved in
both yeast and mammalian cells [18]. Previous work has identiﬁed
the key ubiquitylating enzymes of the UFD pathway in S. cerevisiae,
including E2 Ubc4 and Ubc5, the HECT E3 Ufd4, and the Ub-chain
elongation factor Ufd2 (called E4) [4,16,19–21]. Ufd4 is a 167 kDa
HECT-domain E3 ligase that was shown to recognize the N-termi-
nal ubiquitin degron via its N-terminal domain and ubiquitylate
the UFD substrates [4,16,22]. In addition, Ufd4 targets the E2
Ubc7 [23] and the DNA alkyltransferase Mgt1 (O-6-methylgua-
nine-DNA methyltransferase) for proteasomal degradation [24].
Interestingly, it was recently shown to interact with the N-end rule
E3 Ubr1, leading to enhanced activities of both the N-end rule and
the UFD pathways [25]. Because the ubiquitylation of the UFD sub-
strate requires the presence of K29 of the ubiquitin moiety of the
substrate [4,16], Ufd4 is likely to assemble K29-linked ubiquitin
chains on the ubiquitin-moiety of the UFD substrate. However, re-
cent studies have suggested that Ufd4 might assemble K48-linked
polyubiquitin chains [25,26]. We previously investigated the con-
cept that Ufd4 and Ufd2 assemble different chain types, i.e., Ufd4
and Ufd2 assemble K29- and K48-linked ubiquitin chains, respec-
tively. Although our in vitro study clearly suggested that Ufd2
assembles K48-linked chains onto the Ufd4-preassembled chains,
we failed to detect putative K29-linked chains by Ufd4 [20]. Be-
cause one of the utility of developed ubiquitin PRM method is to
dissect such multi-step ubiquitylation by sequentially acting en-
zymes, we decided to analyze the ubiquitylation of the UFD
substrate.
To investigate the UFD substrate, we generated the yeast cells
that chromosomally expressing Ub-P-bgal. As expected, strong
accumulations of Ub-P-bgal were detected in both Dufd4 and
Dufd2 cells, but the ubiquitylation levels were different among
the wild-type,Dufd4 and Dufd2 cells (Fig. 2A). Consistent with pre-
vious results, the polyubiquitylation of Ub-P-bgal was easily de-
tected in the wild-type and Dufd2 cells while weak
ubiquitylation was observed in the Dufd4 cells (Fig. 2A, bottom).
The immunoprecipitated Ub-P-bgal were further analyzed by
SDS–PAGE (Fig. 2B). Minor protein bands that associated with
Ub-P-bgal were identiﬁed as dimerized form of the substrate itself
and protein chaperones, Hsp70 and Hsp90 family (Fig. 2B, right ta-
ble), indicating that high purity of the immunoprecipitated Ub-P-
bgal sufﬁcient for the ubiquitin quantiﬁcation.
The gel region of polyubiquitylated Ub-P-bgal was excised and
subjected to the ubiquitin PRM analysis (Fig. 3). In wild-type cells,
Ub-P-bgal is modiﬁed with 310 fmol of total ubiquitin, assessed by
two peptides, TITLE and EST. Of these, K29-linked peptide (23
fmol) and K48-linked peptides (89 fmol) were prominent than
other linkages (Fig. 3A). Because the ubiquitin-moiety of Ub-P-bgal
is involved in the calculation of total ubiquitin, the percentage of
the ubiquitin linkages could be underscored (30% of total ubiqui-
tin). Nevertheless, the PRM analysis clearly suggested that the
polyubiquitin chains assembled on Ub-P-bgal consist of 21% of
K29- and 78% of K48-linked chains, respectively (Fig. 3B). Incontrast to the wild-type cells, total ubiquitylation levels were de-
creased to 69 fmol and both K29- and K48-linked chains were
markedly reduced in the Dufd4 cells (Fig. 3A). In the Dufd2 cells,
the total ubiquitin level as well as both chains was decreased by
half, suggesting that compromised chain elongation results in the
substrate stabilization and that other factor(s) working down-
stream of Ufd4 might exist in the cells. Combined with the previ-
ous result that Ufd2 assembles K48-linked chains in vitro [20],
these results suggested that Ufd4 is a unique ubiquitin ligase that
can assemble K29-linked ubiquitin chains in yeast. Interestingly,
other ubiquitin linkages including K6-, K11-, K27-, K33- and K63-
linkages were unambiguously identiﬁed in the ubiquitin chains,
although the sum of their percentage is only 1.2% of total linkages,
suggesting that such chains were mistakenly incorporated into the
UFD substrate, probably by Ufd4 in vivo.
In conclusion, we established the ubiquitin PRM method to
quantify the ubiquitylation levels with highest sensitivity even in
the complex biological samples. Using the ubiquitin PRM, we re-
vealed that Ufd4 assembles K29-linked ubiquitin chains on the
UFD substrate in vivo.
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